Imagine a baseball season that started with high hopes but fizzled out in disappointing fashion – that's the heartache the Baltimore Orioles faced in 2025. But here's where it gets interesting: the team is doubling down on one of its key pitchers, signaling they're not ready to give up on rebuilding momentum just yet. Let's dive into this fresh development and unpack what it means for the Orioles' future.
On December 29, 2025, the Baltimore Orioles made an exciting announcement: they've locked in right-hander Zach Eflin with a one-year contract worth $10 million, ensuring he stays put as the club actively bolsters its lineup following a frustrating 2025 campaign. This deal, confirmed by a source to ESPN's Alden Gonzalez, includes a mutual option for the 2027 season and a nifty $500,000 bonus if Eflin gets traded down the line.
At 31 years old, Eflin battled through a tough year in 2025, plagued by injuries that landed him on the injured list three separate times due to lat and back issues. Despite a solid 4.2% walk rate, his season stats reflected some struggles: a 5.93 ERA over 14 starts, with fewer strikeouts and more home runs allowed – a stark contrast to his impressive 2.60 ERA in nine games for Baltimore after being traded from the Tampa Bay Rays at the 2024 deadline.
And this is the part most people miss: Eflin's role could shift in 2026. While he opened the 2025 season as the Orioles' starting pitcher on Opening Day, expect him to settle into the back of the rotation now that Trevor Rogers is returning healthy from a standout year, Kyle Bradish is fit and ready, and Shane Baz recently joined from the Rays in a prospect-packed trade earlier this month. For beginners in baseball lingo, the rotation is basically the list of pitchers who start games, and 'back end' means he's likely not the ace but a reliable option to keep games going strong.
The Orioles aren't stopping there. They have other in-house talents like Dean Kremer and Tyler Wells to consider, and who knows – they might still scoop up more depth before the winter meetings wrap up. Improving the pitching staff, which sadly ranked 24th in ERA league-wide last year, was a top priority for Orioles president of baseball operations Mike Elias this offseason, alongside bolstering the bullpen and adding right-handed power.
But here's where it gets controversial: Is this $10 million investment in Eflin a savvy move, or are the Orioles overpaying for a pitcher whose recent form has been overshadowed by health woes? Elias has already tackled the other priorities head-on – signing closer Ryan Helsley to a two-year, $28 million pact; swapping Grayson Rodriguez for free-agent outfielder Taylor Ward; and inking first baseman Pete Alonso to a whopping five-year, $155 million deal. MLB Network was the first to spill the beans on Eflin's contract details.
What do you think, fans? Does this re-signing scream 'smart gamble' on Baltimore's part, or is it risky given Eflin's injury history and 2025 performance? Share your thoughts in the comments – do you agree the Orioles should focus more on younger prospects, or is loyalty to a proven arm like Eflin's the way to go? Let's debate!
